Literature DB >> 11734678

Giant cell arteritis: diagnosis and management.

M T Bhatti1, H Tabandeh.   

Abstract

Visual loss caused by giant cell arteritis is a medical emergency that requires prompt recognition and treatment with systemic corticosteroids. A delay in diagnosis can lead to devastating ophthalmic and systemic complications. Recent advances in genetic and immunocytochemical research techniques have led to greater understanding of the underlying pathomechanisms of giant cell arteritis. Giant cell arteritis is a systemic condition with a strong predilection for the ocular vasculature. Visual symptoms are often the presenting manifestation of the disease, placing the ophthalmologist in a critical position for early diagnosis and treatment. Maintenance of a high clinical suspicion in the appropriate clinical setting is important in establishing an early diagnosis. Because of the complex nature of the disease process, many cases may be a therapeutic challenge requiring prolonged immunosuppression.

Entities:  

Mesh:

Year:  2001        PMID: 11734678     DOI: 10.1097/00055735-200112000-00003

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  10 in total

1.  [Fever, redness, swelling, and pain in the submental region].

Authors:  U R Goessler; A Marx; K Hörmann; F Riedel
Journal:  HNO       Date:  2009-06       Impact factor: 1.284

Review 2.  Non-infectious orbital vasculitides.

Authors:  B Perumal; E H Black; F Levin; J J Servat
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

3.  Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis.

Authors:  Hisham M Habib; Ashraf A Essa; Ayman A Hassan
Journal:  Clin Rheumatol       Date:  2011-07-09       Impact factor: 2.980

Review 4.  Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein.

Authors:  A Laria; A Zoli; M Bocci; F Castri; F Federico; G F Ferraccioli
Journal:  Clin Rheumatol       Date:  2012-07-22       Impact factor: 2.980

Review 5.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

Review 6.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

Review 7.  Oral and ocular/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequences.

Authors:  Kosmas I Paraskevas; Dimitrios T Boumpas; George E Vrentzos; Dimitri P Mikhailidis
Journal:  Clin Rheumatol       Date:  2006-12-16       Impact factor: 3.650

8.  Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis.

Authors:  Maria Karahaliou; George Vaiopoulos; Spiros Papaspyrou; Meletios A Kanakis; Konstantinos Revenas; Petros P Sfikakis
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 9.  The thromboembolic risk in giant cell arteritis: a critical review of the literature.

Authors:  A Guida; A Tufano; P Perna; P Moscato; M T De Donato; R Finelli; D Caputo; M N D Di Minno
Journal:  Int J Rheumatol       Date:  2014-05-20

10.  The Adequate Number of Histopathology Cross-sections of Temporal Artery Biopsy in Establishing the Diagnosis of Giant Cell Arteritis.

Authors:  Roshanak Ali-Akbar Navahi; Samira Chaibakhsh; Sayyed Amirpooya Alemzadeh; Kaveh Abri Aghdam
Journal:  J Ophthalmic Vis Res       Date:  2021-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.